1. Canada Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Edesa Biotech, Inc.

Edesa Biotech, Inc.

EDSA
Edesa Biotech, Inc.US flagNASDAQ Capital Market
7.50
USD
-0.25
- -
66.69MMarket Cap

Total Valuation

Edesa Biotech, Inc. carries a market capitalization of 66.69M, placing it among publicly traded companies globally. Its enterprise value stands at 39.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap66.69M
Enterprise Value39.40M

Share Statistics

Edesa Biotech, Inc. currently has 8.89M shares outstanding.

Shares Outstanding8.89M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio-3.04
P/TBV Ratio-390.57
P/FCF Ratio-5.45
P/OCF Ratio-5.45

Financial Position

Edesa Biotech, Inc. maintains a current ratio of 4.76, meaning it holds 4.8x the short-term assets needed to cover near-term liabilities.

Current Ratio4.76
Quick Ratio4.67
Debt / EquityN/A
Debt / EBITDAN/A
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-72.43
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Income Tax800.00
Effective Tax RateN/A

Stock Price Statistics

Edesa Biotech, Inc.'s stock has gained approximately 264.07767% over the past 52 weeks. The 50-day moving average sits at 9.83, while the 200-day moving average is 4.55.

Beta (5Y)N/A
52-Week Price Change264.07767%
50-Day Moving Average9.83
200-Day Moving Average4.55
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -10.31M, while operating income came in at -10.41M.

RevenueN/A
Gross ProfitN/A
Operating Income-10.41M
Pretax Income-10.44M
Net Income-10.44M
EBITDA-10.31M
EBIT-10.41M
Earnings Per Share (EPS)-1.33

Balance Sheet

Total book value stands at -13.52M, with working capital of 8.23M providing operational flexibility.

Cash & Cash Equivalents10.00M
Total DebtN/A
Net Debt-10.00M
Equity (Book Value)-13.52M
Book Value Per Share-1.72
Working Capital8.23M

Cash Flow

Edesa Biotech, Inc. produced -7.53M in operating cash flow over the past twelve months.

Operating Cash Flow-7.53M
Capital ExpendituresN/A
Free Cash Flow-7.53M
FCF Per Share-0.96

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-8.61
FCF Yield-18.34

Stock Splits

Edesa Biotech, Inc.'s most recent stock split took place on October 11, 2023 with a 7:1 split ratio.

Last Split Date10/11/2023
Split Ratio7:1

Scores

Edesa Biotech, Inc. posts an Altman Z-Score of -0.79, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.79